Zinc in PDB 5sey: Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol, PDB code: 5sey
was solved by
C.Joseph,
K.Groebke-Zbinden,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.70 /
2.29
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.139,
135.139,
235.509,
90,
90,
120
|
R / Rfree (%)
|
17.3 /
23.4
|
Other elements in 5sey:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol
(pdb code 5sey). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol, PDB code: 5sey:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5sey
Go back to
Zinc Binding Sites List in 5sey
Zinc binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:40.8
occ:1.00
|
NE2
|
A:HIS563
|
2.1
|
32.1
|
1.0
|
NE2
|
A:HIS529
|
2.1
|
43.2
|
1.0
|
OD1
|
A:ASP674
|
2.1
|
40.5
|
1.0
|
OD2
|
A:ASP564
|
2.1
|
35.3
|
1.0
|
O
|
A:HOH944
|
2.2
|
28.2
|
1.0
|
O
|
A:HOH945
|
2.4
|
36.0
|
1.0
|
CD2
|
A:HIS563
|
2.9
|
35.5
|
1.0
|
CG
|
A:ASP674
|
3.0
|
37.8
|
1.0
|
CE1
|
A:HIS529
|
3.1
|
37.5
|
1.0
|
CG
|
A:ASP564
|
3.1
|
32.5
|
1.0
|
CD2
|
A:HIS529
|
3.2
|
37.9
|
1.0
|
CE1
|
A:HIS563
|
3.2
|
39.5
|
1.0
|
OD2
|
A:ASP674
|
3.2
|
38.9
|
1.0
|
OD1
|
A:ASP564
|
3.6
|
29.1
|
1.0
|
MG
|
A:MG802
|
3.8
|
34.3
|
1.0
|
O
|
A:HOH961
|
4.1
|
29.5
|
1.0
|
CD2
|
A:HIS525
|
4.1
|
36.7
|
1.0
|
CG
|
A:HIS563
|
4.1
|
34.7
|
1.0
|
O
|
A:HOH949
|
4.2
|
39.4
|
1.0
|
ND1
|
A:HIS529
|
4.2
|
38.9
|
1.0
|
ND1
|
A:HIS563
|
4.3
|
31.3
|
1.0
|
CB
|
A:ASP564
|
4.3
|
31.8
|
1.0
|
CG
|
A:HIS529
|
4.3
|
36.7
|
1.0
|
CB
|
A:ASP674
|
4.4
|
38.9
|
1.0
|
NE2
|
A:HIS525
|
4.4
|
38.7
|
1.0
|
O
|
A:HOH904
|
4.6
|
27.9
|
1.0
|
CG2
|
A:VAL533
|
4.8
|
28.8
|
1.0
|
O
|
A:ASP674
|
4.8
|
38.1
|
1.0
|
CA
|
A:ASP674
|
4.9
|
37.1
|
1.0
|
O
|
A:HOH916
|
5.0
|
28.7
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5sey
Go back to
Zinc Binding Sites List in 5sey
Zinc binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:40.0
occ:1.00
|
OD2
|
B:ASP564
|
2.1
|
34.2
|
1.0
|
NE2
|
B:HIS563
|
2.1
|
34.6
|
1.0
|
NE2
|
B:HIS529
|
2.2
|
31.4
|
1.0
|
O
|
B:HOH941
|
2.2
|
28.3
|
1.0
|
OD1
|
B:ASP674
|
2.2
|
38.1
|
1.0
|
O
|
B:HOH969
|
2.4
|
40.1
|
1.0
|
CG
|
B:ASP674
|
3.0
|
33.1
|
1.0
|
CD2
|
B:HIS563
|
3.0
|
35.2
|
1.0
|
CD2
|
B:HIS529
|
3.1
|
31.1
|
1.0
|
CG
|
B:ASP564
|
3.1
|
30.2
|
1.0
|
CE1
|
B:HIS563
|
3.2
|
36.2
|
1.0
|
CE1
|
B:HIS529
|
3.2
|
34.2
|
1.0
|
OD2
|
B:ASP674
|
3.2
|
37.3
|
1.0
|
OD1
|
B:ASP564
|
3.6
|
29.4
|
1.0
|
MG
|
B:MG802
|
3.8
|
33.4
|
1.0
|
O
|
B:HOH960
|
3.9
|
26.5
|
1.0
|
O
|
B:HOH954
|
4.1
|
36.4
|
1.0
|
CD2
|
B:HIS525
|
4.1
|
42.1
|
1.0
|
CG
|
B:HIS563
|
4.2
|
31.4
|
1.0
|
O
|
B:HOH979
|
4.2
|
55.5
|
1.0
|
ND1
|
B:HIS563
|
4.3
|
32.3
|
1.0
|
CG
|
B:HIS529
|
4.3
|
31.0
|
1.0
|
ND1
|
B:HIS529
|
4.3
|
31.3
|
1.0
|
CB
|
B:ASP564
|
4.3
|
31.6
|
1.0
|
CB
|
B:ASP674
|
4.4
|
33.5
|
1.0
|
NE2
|
B:HIS525
|
4.5
|
43.0
|
1.0
|
O
|
B:HOH930
|
4.6
|
31.9
|
1.0
|
CG2
|
B:VAL533
|
4.7
|
33.2
|
1.0
|
CA
|
B:ASP674
|
4.9
|
31.7
|
1.0
|
O
|
B:ASP674
|
4.9
|
35.3
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5sey
Go back to
Zinc Binding Sites List in 5sey
Zinc binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:41.0
occ:1.00
|
O
|
C:HOH925
|
2.0
|
27.4
|
1.0
|
OD2
|
C:ASP564
|
2.1
|
39.0
|
1.0
|
NE2
|
C:HIS529
|
2.1
|
39.6
|
1.0
|
OD1
|
C:ASP674
|
2.2
|
40.8
|
1.0
|
NE2
|
C:HIS563
|
2.2
|
34.0
|
1.0
|
O
|
C:HOH944
|
2.5
|
44.7
|
1.0
|
CG
|
C:ASP674
|
3.1
|
35.1
|
1.0
|
CD2
|
C:HIS563
|
3.1
|
29.8
|
1.0
|
CE1
|
C:HIS529
|
3.1
|
35.0
|
1.0
|
CD2
|
C:HIS529
|
3.2
|
36.3
|
1.0
|
CG
|
C:ASP564
|
3.2
|
34.9
|
1.0
|
OD2
|
C:ASP674
|
3.3
|
36.6
|
1.0
|
CE1
|
C:HIS563
|
3.3
|
32.2
|
1.0
|
OD1
|
C:ASP564
|
3.7
|
35.9
|
1.0
|
MG
|
C:MG802
|
3.7
|
34.9
|
1.0
|
O
|
C:HOH938
|
4.1
|
43.9
|
1.0
|
CD2
|
C:HIS525
|
4.1
|
37.6
|
1.0
|
ND1
|
C:HIS529
|
4.2
|
35.5
|
1.0
|
CG
|
C:HIS563
|
4.3
|
29.0
|
1.0
|
CG
|
C:HIS529
|
4.3
|
34.0
|
1.0
|
O
|
C:HOH968
|
4.3
|
33.9
|
1.0
|
ND1
|
C:HIS563
|
4.4
|
28.9
|
1.0
|
CB
|
C:ASP564
|
4.4
|
32.2
|
1.0
|
NE2
|
C:HIS525
|
4.4
|
34.8
|
1.0
|
CB
|
C:ASP674
|
4.4
|
35.2
|
1.0
|
O
|
C:HOH927
|
4.6
|
33.7
|
1.0
|
O
|
C:HOH973
|
4.8
|
42.5
|
1.0
|
CG2
|
C:VAL533
|
4.8
|
34.6
|
1.0
|
CA
|
C:ASP674
|
4.8
|
37.6
|
1.0
|
O
|
C:ASP674
|
4.9
|
39.2
|
1.0
|
O
|
C:HOH933
|
4.9
|
34.7
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5sey
Go back to
Zinc Binding Sites List in 5sey
Zinc binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with [2- Cyclopropyl-6-[2-(1-Methyl-4-Phenylimidazol-2-Yl)Ethynyl]Imidazo[1,2- B]Pyridazin-3-Yl]Methanol within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:56.0
occ:1.00
|
NE2
|
D:HIS563
|
2.1
|
45.6
|
1.0
|
OD2
|
D:ASP564
|
2.2
|
66.7
|
1.0
|
O
|
D:HOH919
|
2.2
|
34.1
|
1.0
|
NE2
|
D:HIS529
|
2.3
|
48.1
|
1.0
|
O
|
D:HOH912
|
2.3
|
45.6
|
1.0
|
OD1
|
D:ASP674
|
2.3
|
62.3
|
1.0
|
CD2
|
D:HIS563
|
3.0
|
48.1
|
1.0
|
CG
|
D:ASP674
|
3.2
|
55.5
|
1.0
|
CG
|
D:ASP564
|
3.2
|
53.6
|
1.0
|
CD2
|
D:HIS529
|
3.2
|
53.1
|
1.0
|
CE1
|
D:HIS563
|
3.3
|
48.3
|
1.0
|
CE1
|
D:HIS529
|
3.3
|
49.6
|
1.0
|
OD2
|
D:ASP674
|
3.5
|
59.1
|
1.0
|
MG
|
D:MG802
|
3.7
|
52.9
|
1.0
|
OD1
|
D:ASP564
|
3.8
|
56.1
|
1.0
|
O
|
D:HOH909
|
3.8
|
53.0
|
1.0
|
O
|
D:HOH920
|
4.0
|
48.1
|
1.0
|
CD2
|
D:HIS525
|
4.2
|
61.9
|
1.0
|
CG
|
D:HIS563
|
4.2
|
53.9
|
1.0
|
CB
|
D:ASP564
|
4.2
|
49.4
|
1.0
|
ND1
|
D:HIS563
|
4.3
|
49.7
|
1.0
|
CG
|
D:HIS529
|
4.4
|
46.5
|
1.0
|
ND1
|
D:HIS529
|
4.4
|
48.7
|
1.0
|
NE2
|
D:HIS525
|
4.5
|
61.5
|
1.0
|
CB
|
D:ASP674
|
4.5
|
63.8
|
1.0
|
O
|
D:HOH905
|
4.6
|
46.8
|
1.0
|
CG2
|
D:VAL533
|
4.8
|
54.9
|
1.0
|
O
|
D:ASP674
|
4.9
|
65.6
|
1.0
|
CA
|
D:ASP674
|
4.9
|
59.4
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Oct 28 04:47:48 2024
|